Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pakthipa Pattarakosol

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Transfusion Medicine (Oxford, England)|September 12, 2024
Risk factors for red blood cell alloimmunization in patients with hematologic malignancyPakthipa Pattarakosol, Nattarat Lorucharoen, Phandee Watanaboonyongcharoen, et al.
Clinical and Experimental Vaccine Research|May 22, 2023
Immunogenicity of the ChAdOx1 nCoV-19 vaccine in patients with hematologic malignanciesChayapa Thookhamme, Manassamon Navinpipat, Aimwipa Sasakul, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Transfusion Medicine (Oxford, England)|September 12, 2024
Risk factors for red blood cell alloimmunization in patients with hematologic malignancyPakthipa Pattarakosol, Nattarat Lorucharoen, Phandee Watanaboonyongcharoen, et al.
Clinical and Experimental Vaccine Research|May 22, 2023
Immunogenicity of the ChAdOx1 nCoV-19 vaccine in patients with hematologic malignanciesChayapa Thookhamme, Manassamon Navinpipat, Aimwipa Sasakul, et al.
Pageof 1